Research Caveats & Emerging Approach While each therapy has strong research support on its own, studies combining TRT + GLP-1 are still emerging
therefore, antioxidant activity may result from its ability to bind bilirubin, homocysteine, and lipids
April 27, 2011
This can result in an intensified or prolonged high sensation, which may be desirable for some but potentially concerning for others
Daily oral L-carnosine (500 mg, p.o., daily for 3 months) significantly ameliorated the pathophysiological triad of inflammation, oxidative stress, and apoptosis in patients receiving FOLFOX-6 regimen (OXA + 5FU + leucovorin), for instance, decreasing the molondialdehyde (MDA) level (51.8%), nuclear factor-B (NF-B) (27%), and TNF- (36.6%), while increasing Nrf-2 (38.7%) ( Therefore, antioxidant drugs, including small molecular drugs, Mn-based MRI contrast agents, and natural products could alleviate, to some extent, the symptoms of PIPN